96 related articles for article (PubMed ID: 23454288)
1. In vivo assessment of specific cytotoxic T lymphocyte killing.
Clemente T; Dominguez MR; Vieira NJ; Rodrigues MM; Amarante-Mendes GP
Methods; 2013 Jun; 61(2):105-9. PubMed ID: 23454288
[TBL] [Abstract][Full Text] [Related]
2. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.
Juillard V; Villefroy P; Godfrin D; Pavirani A; Venet A; Guillet JG
Eur J Immunol; 1995 Dec; 25(12):3467-73. PubMed ID: 8566039
[TBL] [Abstract][Full Text] [Related]
3. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
[TBL] [Abstract][Full Text] [Related]
4. A sensitive flow cytometry-based cytotoxic T-lymphocyte assay through detection of cleaved caspase 3 in target cells.
He L; Hakimi J; Salha D; Miron I; Dunn P; Radvanyi L
J Immunol Methods; 2005 Sep; 304(1-2):43-59. PubMed ID: 16076473
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors.
Song W; Kong HL; Traktman P; Crystal RG
Hum Gene Ther; 1997 Jul; 8(10):1207-17. PubMed ID: 9215738
[TBL] [Abstract][Full Text] [Related]
6. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
[TBL] [Abstract][Full Text] [Related]
7. Segregation of mechanisms for cytotoxic T lymphocyte killing between lungs and regional lymph nodes subsequent to intratracheal delivery of adenovirus 2 vector.
Wang X; Hillemeyer P; Pascual DW
Viral Immunol; 2003; 16(4):525-39. PubMed ID: 14733739
[TBL] [Abstract][Full Text] [Related]
8. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
[TBL] [Abstract][Full Text] [Related]
9. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
[TBL] [Abstract][Full Text] [Related]
10. A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro.
Ehl S; Klenerman P; Aichele P; Hengartner H; Zinkernagel RM
Eur J Immunol; 1997 Dec; 27(12):3404-13. PubMed ID: 9464829
[TBL] [Abstract][Full Text] [Related]
11. Persistence, immune specificity, and functional ability of murine mutant ras epitope-specific CD4(+) and CD8(+) T lymphocytes following in vivo adoptive transfer.
Bristol JA; Schlom J; Abrams SI
Cell Immunol; 1999 May; 194(1):78-89. PubMed ID: 10357883
[TBL] [Abstract][Full Text] [Related]
12. MHC-unrestricted transfer of antilisterial immunity by freshly isolated immune CD8 spleen cells.
Lukacs K; Kurlander RJ
J Immunol; 1989 Dec; 143(11):3731-6. PubMed ID: 2479688
[TBL] [Abstract][Full Text] [Related]
13. Response to Listeria monocytogenes in mice lacking MHC class Ia molecules.
Seaman MS; Pérarnau B; Lindahl KF; Lemonnier FA; Forman J
J Immunol; 1999 May; 162(9):5429-36. PubMed ID: 10228021
[TBL] [Abstract][Full Text] [Related]
14. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
[TBL] [Abstract][Full Text] [Related]
15. Adoptive immunotherapy of a newly induced sarcoma: immunologic characteristics of effector cells.
Shu S; Rosenberg SA
J Immunol; 1985 Oct; 135(4):2895-903. PubMed ID: 2411817
[TBL] [Abstract][Full Text] [Related]
16. The cytotoxic T lymphocyte response against a protein antigen does not decrease the antibody response to that antigen although antigen-pulsed B cells can be targets.
Wang W; Golding B
Immunol Lett; 2005 Sep; 100(2):195-201. PubMed ID: 15916814
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin-fusion degradation pathway plays an indispensable role in naked DNA vaccination with a chimeric gene encoding a syngeneic cytotoxic T lymphocyte epitope of melanocyte and green fluorescent protein.
Zhang M; Ishii K; Hisaeda H; Murata S; Chiba T; Tanaka K; Li Y; Obata C; Furue M; Himeno K
Immunology; 2004 Aug; 112(4):567-74. PubMed ID: 15270727
[TBL] [Abstract][Full Text] [Related]
18. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo.
Yang Y; Jooss KU; Su Q; Ertl HC; Wilson JM
Gene Ther; 1996 Feb; 3(2):137-44. PubMed ID: 8867861
[TBL] [Abstract][Full Text] [Related]
19. Tracing tolerance and immunity in vivo by CFSE-labeling of administered cells.
Ingulli E
Methods Mol Biol; 2007; 380():365-76. PubMed ID: 17876106
[TBL] [Abstract][Full Text] [Related]
20. Theiler's virus infection of genetically susceptible mice induces central nervous system-infiltrating CTLs with no apparent viral or major myelin antigenic specificity.
Lin X; Pease LR; Murray PD; Rodriguez M
J Immunol; 1998 Jun; 160(11):5661-8. PubMed ID: 9605173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
